-
Jacob Berchuck, MD; Dana-Farber Cancer Institute; 5Live #GU22
5:13
Key Insights from the ASCO Genitourinary Cancers Symposium #GU22
-
Arlene Siefker-Radtke, MD; MD Anderson Cancer Center; 5Live; #ASCOGU21
7:46
-
Felix Feng, MD; University of California, San Francisco; 5Live; #ASCOGU21
6:28
-
Thomas Hutson, DO, PharmD, FACP; Texas Oncology; 5Live; #ASCOGU21
8:27
-
Neal Shore, MD, FACS; Atlantic Urology Clinics Carolina Urology Research Center; 5Live; #ASCOGU21
6:24
-
Andrea Apolo, MD; National Cancer Institute; 5Live; #ASCOGU21
6:09
-
Pooja Ghatalia, MD; Fox Chase Cancer Center; 5Live; #ASCOGU21
8:47
-
Matthew Zibelman, MD; Fox Chase Cancer Center; 5Live; #ASCOGU21
4:36
-
Thomas Powles, MD; Barts Cancer Institute; 5Live; #ASCOGU21
4:33
-
Bradley A. McGregor, MD; Dana-Farber Cancer Institute; 5Live; #ASCOGU21
7:14
-
Monika Joshi, MD Penn State University; 5Live; #ASCOGU21
11:57
- Next Page
ABOUT
Bio Ascend is an independent medical education company committed to supporting healthcare providers in their efforts to translate innovative science into clinical practice.
The Bio Ascend team has deep oncology and hematology expertise with a proven ability to distill complex scientific ideas into their essential components, as well as extensive experience in planning, executing, and assessing meaningful education for clinicians.
CONNECT
© Copyright 2021 Bio Ascend, a Vaniam Group company